In this report, the United States POC Diagnostics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of POC Diagnostics in these regions, from 2013 to 2025 (forecast).

United States POC Diagnostics market competition by top manufacturers/players, with POC Diagnostics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinics
Hospitals
Laboratory
Others